0001209191-21-040326.txt : 20210614
0001209191-21-040326.hdr.sgml : 20210614
20210614182026
ACCESSION NUMBER: 0001209191-21-040326
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210610
FILED AS OF DATE: 20210614
DATE AS OF CHANGE: 20210614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: APPLE ROBERT F
CENTRAL INDEX KEY: 0001054942
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32302
FILM NUMBER: 211015995
MAIL ADDRESS:
STREET 1: C/O INKLINE PHARMACEUTICAL CO INC
STREET 2: SENTRY PARK EAST 1720 WALTON ROAD
CITY: BLUE BELL
STATE: PA
ZIP: 19422
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANTARES PHARMA, INC.
CENTRAL INDEX KEY: 0001016169
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411350192
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
BUSINESS PHONE: 609-359-3020
MAIL ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20060120
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20020520
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/
DATE OF NAME CHANGE: 20010604
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-10
0
0001016169
ANTARES PHARMA, INC.
ATRS
0001054942
APPLE ROBERT F
C/O ANTARES PHARMA, INC.
100 PRINCETON SOUTH, SUITE 300
EWING
NJ
08628
1
1
0
0
President & CEO
Common Stock
2021-06-10
4
A
0
248869
4.42
A
2495839
D
Common Stock
2021-06-11
4
F
0
58317
4.45
D
2437522
D
Common Stock
2021-06-13
4
F
0
40892
4.45
D
2396630
D
Stock Option (right to buy)
4.42
2021-06-10
4
A
0
474629
0.00
A
2031-06-10
Common Stock
474629
474629
D
Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest in three equal annual installments from the date of grant.
Represents the payment of tax liability using a portion of securities received from the company in connection with the vesting of a previously granted restricted stock unit award. The shares of common stock reported herein were withheld by the company to cover tax liability and not actually sold.
Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.
The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date.
/s/Lisa M. Kallebo as attorney-in-fact for Robert F. Apple
2021-06-14